JRSH
Jerash Holdings (US), Inc.
JRSH has the edge over NIO overall, supported by stronger modeled upside and lower modeled downside.
NIO
NIO Inc.
NIO's outlook is improving, though it still trails on the overall score.
JRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
JRSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
JRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $4.11 | -44% |
| Fair | 14x | $6.75 | -8.1% |
| Current | 15x | $7.35 | — |
| Forward | 15x | $7.35 | — |
| Expensive | 26x | $12.70 | +73% |
Historical ranges are pointers, not guarantees.
JRSH's PE is in its fair range at 15.0x. On analysts' estimates for next year's earnings, today's price would be 15.2x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
JRSH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for JRSH, with profitability improving.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
JRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.49 | -1% |
| Q3 2026 | $0.49 | +717% |
| Q2 2026 | $0.37 | +429% |
| Q1 2026 | $0.27 | +$0.34 |
| Q4 2025 | $0.15 | +$0.46 |
| Q3 2025 | $0.06 | +$0.35 |
| Q2 2025 | $0.07 | +$0.38 |
| Q1 2025 | -$0.07 | +$0.09 |
| Q4 2024 | -$0.31 | -$0.24 |
JRSH has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
JRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.3M | +20% |
| Q2 2026 | $50.2M | +27% |
| Q1 2026 | $42.9M | +47% |
| Q4 2025 | $41.8M | +18% |
| Q3 2025 | $42M | +4.3% |
| Q2 2025 | $39.6M | -3.2% |
| Q1 2025 | $29.3M | +36% |
| Q4 2024 | $35.4M | +29% |
JRSH has the edge over NIO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +3.5 points |
| Q2 2026 | 5.2% | +2.8 points |
| Q1 2026 | 5.5% | +4 points |
| Q4 2025 | 4.7% | +2.7 points |
| Q3 2025 | 2.6% | -0.2 points |
| Q2 2025 | 2.4% | +4.4 points |
| Q1 2025 | 1.5% | +16 points |
| Q4 2024 | 2% | +0.6 points |
JRSH has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
JRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4M | -32% |
| Q2 2026 | $2.3M | +$9.3M |
| Q1 2026 | $1.8M | +21% |
| Q4 2025 | -$3.9M | -$750.5K |
| Q3 2025 | $6.4M | +46% |
| Q2 2025 | -$6.9M | -$4.6M |
| Q1 2025 | $1.5M | +$7.3M |
| Q4 2024 | -$3.2M | -$2.7M |
JRSH's free cash flow has turned positive after two years mostly in the red: $5M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
JRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -4.6x | Net Cash |
| Q4 2024 | -13.3x | Net Cash |
JRSH has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 84.7 | Overbought |
| Stochastic | 74.8 | Neutral |
JRSH's weekly RSI is 85 (overbought) and its Stochastic is 75 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
JRSH PE vs Consumer Cyclical Sector
| Metric | JRSH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 58 | 47 | 11 pts above |
JRSH is trading at 15x earnings, a 17% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
JRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.21 | 18% above |
| 20 week MA | $5.50 | 34% above |
| 50 week MA | $4.16 | 77% above |
| 100 week MA | $3.75 | 96% above |
| 200 week MA | $3.60 | 104% above |
JRSH has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
JRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.02 | $5.52 | -8.3% |
| 2021 | $5.52 | $6.70 | +21% |
| 2022 | $6.70 | $4.03 | -40% |
| 2023 | $4.03 | $3.11 | -23% |
| 2024 | $3.11 | $3.43 | +10% |
| 2025 | $3.43 | $3.03 | -12% |
| 2026 YTD | $3.03 | $7.35 | +143% |
JRSH has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.